Quantics optimizes pre-clinical programs, ensuring that the maximum available information is extracted from the experimental data. Utilising Quality by Design principles can reduce pre-clinical development time and costs and increasing reliability going forward to Phase 1.

Making the maximum use of pre-clinical efficacy and toxicology data by well planned experimental design and analysis results in more reliable Phase 1 planning, faster go or no-go decisions, and creates a more persuasive argument for investors. Quantics can help you with in vitro biological assays or with in vivo models, and can analyse and report your data in a clear and concise manner.
Design of experiments (DOE) and optimal analysis of data from in vivo models of infection/disease, can  reduce and refine the use of animals in these systems.